rp_pant

[rp_pant @pant_rashmi]

Rashmi Pant’s Market Research Products & Services can help you

RE Frame RE Organize
RE Purpose RE Plenish
RE Generate RE Shape
RE Think

[rp_pant @pant_rashmi]

Big pharma 'needs to replace drugs coming off patent'

https://t.co/HNiHoG8uF2

[rp_pant @pant_rashmi]

@Urs__01 Mobile phone in the girls purse

[rp_pant @pant_rashmi]

Pharma dept sanctions ₹1600 cr for 41 projects under PRIP

https://t.co/ye3xlRqVsr

[rp_pant @pant_rashmi]

AI drug discovery: Focusing on what matters most

https://t.co/9jsgR6qvX2

[rp_pant @pant_rashmi]

12 Companies in fray for CDSCO s new digital digital system

https://t.co/GpJsK89MuU

[rp_pant @pant_rashmi]

CRO consolidation keeps rolling. What does that mean for pharma?
While M&A expands one-stop shop capabilities at large CROs, pharma companies could face tradeoffs around niche expertise and service continuity

https://t.co/8fe5321XlP

[rp_pant @pant_rashmi]

News Analysis
What the age of GLP-1 generics will mean

https://t.co/60WOG9IeZW

[rp_pant @pant_rashmi]

@Osmanjcx0 Straw is closed from the top in image 2

[rp_pant @pant_rashmi]

@Osmanjcx0 2

[rp_pant @pant_rashmi]

Researchers used Olmo 3 and its open training data to show that models can infer a drug’s class from its name instead of knowing the specific medication, and traced that shortcut to how often drugs appeared in training. https://t.co/mCeCADF8VD

[rp_pant @pant_rashmi]

Ai2 and Providence Swedish Cancer Institute partner to advance AI-assisted scientific discovery. collaboration includes clinically meaningful research findings on lobular breast cancer, local deployment to enable next-gen discovery -https://t.co/ulQ4VmS7RK

[rp_pant @pant_rashmi]

Success in APAC region requires local knowledge and globally consistent execution

https://t.co/uBR4uh5cC0

[rp_pant @pant_rashmi]

Beyond the Patent Cliff: Why Generics and Biosimilars Demand Different Playbooks

https://t.co/p7gOX2AwxQ

[rp_pant @pant_rashmi]

$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret

https://t.co/1pYQPVl0nQ

[rp_pant @pant_rashmi]

Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program

https://t.co/L3X2bLBgtl

[rp_pant @pant_rashmi]

When the Slack Runs Out: AI and the CRO Operating Model

https://t.co/yBnQHEh1en

[rp_pant @pant_rashmi]

FDA/Center for Research on Complex Generics (CRCG) Workshop on Advancing Bioequivalence Frameworks for Inhalation Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods
OCTOBER 14 - 15, 2026

https://t.co/TGdOMVHUO6

[rp_pant @pant_rashmi]

Brain capital is emerging as a defining factor in human flourishing, economic resilience, and societal prosperity. But are we investing in it with the urgency it deserves?

https://t.co/3QmZ2NPQ32